RE:RE:RE:RE:RE:CFO and CEO Organigram have to wake up !!
Good question: who will be left standing. Sure, WEED and CRON have the deepest pockets. Cash on hand alone though is nowhere near determinative of future performance. Rather, it comes down to management. That said, OGI of course needs cash to operate and grow. Whether they will need to do another raise, debt or equity, is an open question but certainly a possibility. As for the current BMO loan facility, here's the public info:
"The facility consists of a $115 million term loan and a $25 million revolving credit facility (together, the "Facilities"), both of which mature in May 2022. Included in the facility is an uncommitted option to increase the Facilities by an incremental $35 million to a total of $175 million.
Pursuant to the agreed upon conditions of the Facilities, Organigram has initially drawn $50 million of the term loan on closing and can continue to draw down additional funds as required up to the $115 million term loan commitment through to November 30, 2019. Principal repayments on the term loan will commence on February 28, 2020 at a rate of 2.5%, or approximately $2.9 million, per quarter thereafter. The Company may, at its discretion, repay the balance of the Facilities without penalty, at any time."